MOLN
Molecular Partners AG American Depositary Shares
Biological Products, (No Diagnostic Substances)
Best Biotech Stocks 2026 →
Molecular Partners (MOLN) Stock: Buy, Sell, or Hold?
$2.94
-0.07 (-2.33%)
▼
5d:
-9.45%
30d:
-22.43%
90d:
-26.5%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (62%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$3.24 – $3.79
Position: OVERSOLD
Forward P/E & Valuation
-27.7x
CHEAP
vs 31.9x historical avg
Wall Street Target
$10.00
+240.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.75 / $3.74
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: MOLN shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When MOLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: MOLN is currently trading at $2.94, which is considered oversold relative to its 30-day fair value range of $3.24 to $3.79. From a valuation perspective, the stock is trading at a discount (Forward PE: -27.7) compared to its historical average (31.9). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MOLN is in a downtrend. Immediate support is located at $2.75, while resistance sits at $3.74.
Market Sentiment: MOLN scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.99 (+240.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MOLN is in a downtrend. Immediate support is located at $2.75, while resistance sits at $3.74.
Market Sentiment: MOLN scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.99 (+240.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.24 -
$3.79
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
Trading Range & Key Levels
30-Day Trading Range
$3.24 -
$3.79
Current vs Trading Range
OVERSOLD
Support Level
$2.75
Resistance Level
$3.74
Current Trend
Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 240.0% below Wall St target ($9.99)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-27.74
Wall Street Target
$10.00
(+240.0%)
Revenue Growth (YoY)
-100.0%
PE vs Historical
-27.7 vs 31.9
CHEAP
Share MOLN Analysis
Share this live MOLN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 14, 2026 11:57 PM ET
Data refreshes hourly during market hours. Next update: 12:57 AM
Data refreshes hourly during market hours. Next update: 12:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MOLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 43 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 63 BUY |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 43 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
18 analysts |
$72 | 31 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive MOLN Research Pages
